Summary

The global Forensic Drug Analysis Solutions market is projected to grow from US$ 1426 million in 2025 to US$ 2324 million by 2032, at a CAGR of 7.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Forensic Drug Analysis Solutions are professional integrated systems combining technical tools, methodologies, and services to identify, quantify, and analyze illegal drugs, controlled substances, and their metabolites in forensic investigations. They integrate sample preparation, analytical instruments, data processing, and expert interpretation to provide accurate, legally admissible results for law enforcement, judicial proceedings, and public safety purposes.
Demand for Forensic Drug Analysis Solutions is driven by rising global drug-related crimes, stricter drug control regulations, the need for rapid and accurate forensic evidence, and advancements in analytical technology. Business opportunities lie in developing high-sensitivity analytical tools, portable on-site detection solutions, customized services for law enforcement, and integrating AI for data analysis to meet the growing demand for efficient, reliable forensic drug testing.
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Forensic Drug Analysis Solutions market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Analytical Technology and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Bruker
SOCOTEC
SCIEX
Aerovest Drug Expert Witness
Bureau Veritas
HNL Lab Medicine
Key Forensic Services
Thermo Fisher Scientific
NMS Labs
Eurofins Forensic Services
Abbott Toxicology
Segment by Analytical Technology
Chromatography-Based Analysis
Mass Spectrometry Analysis
Immunoassay Analysis
Segment by Detection Scope
Illegal Drug
Controlled Substance
Drug Metabolite
Segment by Operation Mode
Laboratory-Based
On-Site Rapid
Portable Detection
Segment by Application
Law Enforcement
Judicial Forensic
Forensic Laboratory
Segment by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Forensic Drug Analysis Solutions study scope, segments the market by Analytical Technology and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Forensic Drug Analysis Solutions: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Analytical Technology
1.2.1 Global Forensic Drug Analysis Solutions Market Size by Analytical Technology, 2021 vs 2025 vs 2032
1.2.2 Chromatography-Based Analysis
1.2.3 Mass Spectrometry Analysis
1.2.4 Immunoassay Analysis
1.3 Market Segmentation by Detection Scope
1.3.1 Global Forensic Drug Analysis Solutions Market Size by Detection Scope, 2021 vs 2025 vs 2032
1.3.2 Illegal Drug
1.3.3 Controlled Substance
1.3.4 Drug Metabolite
1.4 Market Segmentation by Operation Mode
1.4.1 Global Forensic Drug Analysis Solutions Market Size by Operation Mode, 2021 vs 2025 vs 2032
1.4.2 Laboratory-Based
1.4.3 On-Site Rapid
1.4.4 Portable Detection
1.5 Market Segmentation by Application
1.5.1 Global Forensic Drug Analysis Solutions Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Law Enforcement
1.5.3 Judicial Forensic
1.5.4 Forensic Laboratory
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Forensic Drug Analysis Solutions Revenue Estimates and Forecasts (2021-2032)
2.2 Global Forensic Drug Analysis Solutions Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Forensic Drug Analysis Solutions Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Forensic Drug Analysis Solutions Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Chromatography-Based Analysis: Market Share by Key Players
3.3.2 Mass Spectrometry Analysis: Market Share by Key Players
3.3.3 Immunoassay Analysis: Market Share by Key Players
3.4 Global Forensic Drug Analysis Solutions Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Forensic Drug Analysis Solutions Market by Analytical Technology
4.1.1 Global Revenue by Analytical Technology (2021-2032)
4.1.2 Global Revenue-Based Market Share by Analytical Technology (2021-2032)
4.2 Global Forensic Drug Analysis Solutions Market by Detection Scope
4.2.1 Global Revenue by Detection Scope (2021-2032)
4.2.2 Global Revenue-Based Market Share by Detection Scope (2021-2032)
4.3 Global Forensic Drug Analysis Solutions Market by Operation Mode
4.3.1 Global Revenue by Operation Mode (2021-2032)
4.3.2 Global Revenue-Based Market Share by Operation Mode (2021-2032)
4.4 Key Product Attributes and Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Forensic Drug Analysis Solutions Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Forensic Drug Analysis Solutions Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Forensic Drug Analysis Solutions Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Forensic Drug Analysis Solutions Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Forensic Drug Analysis Solutions Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Forensic Drug Analysis Solutions Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Forensic Drug Analysis Solutions Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Forensic Drug Analysis Solutions Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Forensic Drug Analysis Solutions Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Forensic Drug Analysis Solutions Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Forensic Drug Analysis Solutions Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Bruker
11.1.1 Bruker Corporation Information
11.1.2 Bruker Business Overview
11.1.3 Bruker Forensic Drug Analysis Solutions Product Features and Attributes
11.1.4 Bruker Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.1.5 Bruker Forensic Drug Analysis Solutions Revenue by Product in 2025
11.1.6 Bruker Forensic Drug Analysis Solutions Revenue by Application in 2025
11.1.7 Bruker Forensic Drug Analysis Solutions Revenue by Geographic Area in 2025
11.1.8 Bruker Forensic Drug Analysis Solutions SWOT Analysis
11.1.9 Bruker Recent Developments
11.2 SOCOTEC
11.2.1 SOCOTEC Corporation Information
11.2.2 SOCOTEC Business Overview
11.2.3 SOCOTEC Forensic Drug Analysis Solutions Product Features and Attributes
11.2.4 SOCOTEC Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.2.5 SOCOTEC Forensic Drug Analysis Solutions Revenue by Product in 2025
11.2.6 SOCOTEC Forensic Drug Analysis Solutions Revenue by Application in 2025
11.2.7 SOCOTEC Forensic Drug Analysis Solutions Revenue by Geographic Area in 2025
11.2.8 SOCOTEC Forensic Drug Analysis Solutions SWOT Analysis
11.2.9 SOCOTEC Recent Developments
11.3 SCIEX
11.3.1 SCIEX Corporation Information
11.3.2 SCIEX Business Overview
11.3.3 SCIEX Forensic Drug Analysis Solutions Product Features and Attributes
11.3.4 SCIEX Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.3.5 SCIEX Forensic Drug Analysis Solutions Revenue by Product in 2025
11.3.6 SCIEX Forensic Drug Analysis Solutions Revenue by Application in 2025
11.3.7 SCIEX Forensic Drug Analysis Solutions Revenue by Geographic Area in 2025
11.3.8 SCIEX Forensic Drug Analysis Solutions SWOT Analysis
11.3.9 SCIEX Recent Developments
11.4 Aerovest Drug Expert Witness
11.4.1 Aerovest Drug Expert Witness Corporation Information
11.4.2 Aerovest Drug Expert Witness Business Overview
11.4.3 Aerovest Drug Expert Witness Forensic Drug Analysis Solutions Product Features and Attributes
11.4.4 Aerovest Drug Expert Witness Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.4.5 Aerovest Drug Expert Witness Forensic Drug Analysis Solutions Revenue by Product in 2025
11.4.6 Aerovest Drug Expert Witness Forensic Drug Analysis Solutions Revenue by Application in 2025
11.4.7 Aerovest Drug Expert Witness Forensic Drug Analysis Solutions Revenue by Geographic Area in 2025
11.4.8 Aerovest Drug Expert Witness Forensic Drug Analysis Solutions SWOT Analysis
11.4.9 Aerovest Drug Expert Witness Recent Developments
11.5 Bureau Veritas
11.5.1 Bureau Veritas Corporation Information
11.5.2 Bureau Veritas Business Overview
11.5.3 Bureau Veritas Forensic Drug Analysis Solutions Product Features and Attributes
11.5.4 Bureau Veritas Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.5.5 Bureau Veritas Forensic Drug Analysis Solutions Revenue by Product in 2025
11.5.6 Bureau Veritas Forensic Drug Analysis Solutions Revenue by Application in 2025
11.5.7 Bureau Veritas Forensic Drug Analysis Solutions Revenue by Geographic Area in 2025
11.5.8 Bureau Veritas Forensic Drug Analysis Solutions SWOT Analysis
11.5.9 Bureau Veritas Recent Developments
11.6 HNL Lab Medicine
11.6.1 HNL Lab Medicine Corporation Information
11.6.2 HNL Lab Medicine Business Overview
11.6.3 HNL Lab Medicine Forensic Drug Analysis Solutions Product Features and Attributes
11.6.4 HNL Lab Medicine Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.6.5 HNL Lab Medicine Recent Developments
11.7 Key Forensic Services
11.7.1 Key Forensic Services Corporation Information
11.7.2 Key Forensic Services Business Overview
11.7.3 Key Forensic Services Forensic Drug Analysis Solutions Product Features and Attributes
11.7.4 Key Forensic Services Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.7.5 Key Forensic Services Recent Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Corporation Information
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Forensic Drug Analysis Solutions Product Features and Attributes
11.8.4 Thermo Fisher Scientific Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.8.5 Thermo Fisher Scientific Recent Developments
11.9 NMS Labs
11.9.1 NMS Labs Corporation Information
11.9.2 NMS Labs Business Overview
11.9.3 NMS Labs Forensic Drug Analysis Solutions Product Features and Attributes
11.9.4 NMS Labs Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.9.5 NMS Labs Recent Developments
11.10 Eurofins Forensic Services
11.10.1 Eurofins Forensic Services Corporation Information
11.10.2 Eurofins Forensic Services Business Overview
11.10.3 Eurofins Forensic Services Forensic Drug Analysis Solutions Product Features and Attributes
11.10.4 Eurofins Forensic Services Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Abbott Toxicology
11.11.1 Abbott Toxicology Corporation Information
11.11.2 Abbott Toxicology Business Overview
11.11.3 Abbott Toxicology Forensic Drug Analysis Solutions Product Features and Attributes
11.11.4 Abbott Toxicology Forensic Drug Analysis Solutions Revenue and Gross Margin (2021-2026)
11.11.5 Abbott Toxicology Recent Developments
12 Forensic Drug Analysis Solutions Value Chain and Ecosystem Analysis
12.1 Forensic Drug Analysis Solutions Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Forensic Drug Analysis Solutions Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Forensic Drug Analysis Solutions Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details